Neko Health $700M Series C

A 60-minute radiation-free scan caught medically significant findings in 6.4% of patients who thought they were fine - and Lightspeed just bet $700 million that Americans will pay cash to find out what is wrong before it gets expensive.

The US healthcare system generated $4.5 trillion in revenue in 2025. Almost none of it was for keeping people well.

That is not a quirk of bad management or missed opportunity. It is the architecture. Every reimbursement code, every payment model, every hospital margin structure is optimized around treating illness - not preventing it. The incentives that govern American medicine make prevention economically irrational for the institutions best positioned to deliver it.

Neko Health just raised $700 million betting that a growing segment of consumers will pay out of pocket to route around that structure entirely.

The Series C, led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, closed in July 2026 at a valuation of nearly $7 billion. That is roughly four times the company's valuation from early 2025 - one of the steepest 18-month appreciation curves in digital health this decade. Co-founders Daniel Ek, known for building Spotify, and CEO Hjalmar Nilsonne have already p…